Squarepoint’s BrightSpring Health Services BTSG Stock Holding History

Squarepoint’s Portfolio BTSG Stock Details BTSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-17,700	Closed	-$320K	–	5168
2025 Q1	$320K	Buy	+17,700	New	+$348K	﹤0.01%	3694

Other funds holding BTSG

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Squarepoint's BTSG Position: Q2 2026 in Review

Squarepoint sold out of BrightSpring Health Services (BTSG) in Q2 2026, closing a stake of 58,299 shares — an estimated $2.48M sold.

Squarepoint first reported a position in BTSG in Q3 2024 and held it in 6 quarters. The position peaked at $7.24M in Q4 2025. 423 funds tracked by Wall St. Rank hold BTSG as of Q2 2026.

Squarepoint reported no remaining BrightSpring Health Services position as of Q2 2026 after selling out during the quarter.
Squarepoint sold 58,299 BrightSpring Health Services shares in Q2 2026, an estimated $2.48M.
Squarepoint first reported a position in BrightSpring Health Services in Q3 2024 and held it in 6 quarters.
Squarepoint's BrightSpring Health Services position peaked at $7.24M in Q4 2025.
423 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.